Free preview
MD Pharmacology NMC syllabus ~5 min read Recent advances last updated on 2026-07-02

Screening of Antitussive Drugs

Experimental evaluation of cough-suppressant drugs — the validated animal models (irritant-inhalation, mechanical, superior-laryngeal-nerve), apparatus, cough-induction methods, measured endpoints, and reference standards. A lab-methods topic, not clinical antitussive pharmacotherapy.

Introduction & the cough reflex arc

  • Definition — An antitussive suppresses cough; screening a candidate means demonstrating, in a validated animal model, that pre-treatment reduces an experimentally evoked cough compared with the animal's own control response.
  • Cough is a reflex — Every antitussive assay exploits the reflex arc: cough receptors (mechano/chemo-sensitive) concentrated at the tracheal bifurcation (carina) and larynx/large bronchi → vagal afferents (mainly the superior laryngeal nerve) → a medullary "cough centre" → efferents that close the glottis and drive the forced expiratory thrust.
  • Two logical handles — A screen (i) induces cough by a reproducible peripheral stimulus, then (ii) quantifies how the test drug changes a defined endpoint (cough number / latency / expiratory force) versus a reference standard.
  • Site-of-action discrimination — Irritant-inhalation and mechanical models detect both peripherally- and centrally-acting antitussives, whereas the superior-laryngeal-nerve model "cannot detect compounds which act on cough receptors in the bronchial area" — so it is selective for centrally active agents such as codeine.
Figure 1 — Screening of Antitussive Drugs
Figure 1 — Screening of Antitussive Drugs
Continue reading

Screening Antitussive Drugs

PharmaNotes Pro · LAQ

Sign in with your Google account. If you're already subscribed, the chapter unlocks immediately — otherwise, pick Monthly or Annual on the next step.